Literature DB >> 19875504

Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.

Thomas H Chase1, Gregory A Cox, Lisa Burzenski, Oded Foreman, Leonard D Shultz.   

Abstract

Limb-girdle muscular dystrophy 2B, Miyoshi myopathy, and distal myopathy of anterior tibialis are severely debilitating muscular dystrophies caused by genetically determined dysferlin deficiency. In these muscular dystrophies, it is the repair, not the structure, of the plasma membrane that is impaired. Though much is known about the effects of dysferlin deficiency in skeletal muscle, little is known about the role of dysferlin in maintenance of cardiomyocytes. Recent evidence suggests that dysferlin deficiency affects cardiac muscle, leading to cardiomyopathy when stressed. However, neither the morphological location of dysferlin in the cardiomyocyte nor the progression of the disease with age are known. In this study, we examined a mouse model of dysferlinopathy using light and electron microscopy as well as echocardiography and conscious electrocardiography. We determined that dysferlin is normally localized to the intercalated disk and sarcoplasm of the cardiomyocytes. In the absence of dysferlin, cardiomyocyte membrane damage occurs and is localized to the intercalated disk and sarcoplasm. This damage results in transient functional deficits at 10 months of age, but, unlike in skeletal muscle, the cell injury is sublethal and causes only mild cardiomyopathy even at advanced ages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875504      PMCID: PMC2789639          DOI: 10.2353/ajpath.2009.080930

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Contraction-induced cell wounding and release of fibroblast growth factor in heart.

Authors:  M S Clarke; R W Caldwell; H Chiao; K Miyake; P L McNeil
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

2.  Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.

Authors:  R E Bittner; L V Anderson; E Burkhardt; R Bashir; E Vafiadaki; S Ivanova; T Raffelsberger; I Maerk; H Höger; M Jung; M Karbasiyan; M Storch; H Lassmann; J A Moss; K Davison; R Harrison; K M Bushby; A Reis
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Myocardial fibrosis assessment by semiquantitative, point-counting and computer-based methods in patients with heart muscle disease: a comparative study.

Authors:  J D Vasiljević; Z B Popović; P Otasević; Z V Popović; R Vidaković; M Mirić; A N Nesković
Journal:  Histopathology       Date:  2001-04       Impact factor: 5.087

4.  Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy.

Authors:  C Matsuda; M Aoki; Y K Hayashi; M F Ho; K Arahata; R H Brown
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

5.  Defective membrane repair in dysferlin-deficient muscular dystrophy.

Authors:  Dimple Bansal; Katsuya Miyake; Steven S Vogel; Séverine Groh; Chien-Chang Chen; Roger Williamson; Paul L McNeil; Kevin P Campbell
Journal:  Nature       Date:  2003-05-08       Impact factor: 49.962

6.  Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Authors:  Mengfatt Ho; Cristina M Post; Leah R Donahue; Hart G W Lidov; Roderick T Bronson; Holly Goolsby; Simon C Watkins; Gregory A Cox; Robert H Brown
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

7.  Dysferlin is a plasma membrane protein and is expressed early in human development.

Authors:  L V Anderson; K Davison; J A Moss; C Young; M J Cullen; J Walsh; M A Johnson; R Bashir; S Britton; S Keers; Z Argov; I Mahjneh; F Fougerousse; J S Beckmann; K M Bushby
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

8.  Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies.

Authors:  Cristina Basso; Elzbieta Czarnowska; Mila Della Barbera; Barbara Bauce; Giorgia Beffagna; Elzbieta K Wlodarska; Kalliopi Pilichou; Angelo Ramondo; Alessandra Lorenzon; Olgierd Wozniek; Domenico Corrado; Luciano Daliento; Gian Antonio Danieli; Marialuisa Valente; Andrea Nava; Gaetano Thiene; Alessandra Rampazzo
Journal:  Eur Heart J       Date:  2006-06-14       Impact factor: 29.983

9.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.

Authors:  R Bashir; S Britton; T Strachan; S Keers; E Vafiadaki; M Lako; I Richard; S Marchand; N Bourg; Z Argov; M Sadeh; I Mahjneh; G Marconi; M R Passos-Bueno; E de S Moreira; M Zatz; J S Beckmann; K Bushby
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

10.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

Authors:  J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

View more
  31 in total

1.  Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair.

Authors:  Peihui Lin; Hua Zhu; Chuanxi Cai; Xianhua Wang; Chunmei Cao; Ruiping Xiao; Zui Pan; Noah Weisleder; Hiroshi Takeshima; Jianjie Ma
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

2.  Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy.

Authors:  Noah Weisleder; Norio Takizawa; Peihui Lin; Xianhua Wang; Chunmei Cao; Yan Zhang; Tao Tan; Christopher Ferrante; Hua Zhu; Pin-Jung Chen; Rosalie Yan; Matthew Sterling; Xiaoli Zhao; Moonsun Hwang; Miyuki Takeshima; Chuanxi Cai; Heping Cheng; Hiroshi Takeshima; Rui-Ping Xiao; Jianjie Ma
Journal:  Sci Transl Med       Date:  2012-06-20       Impact factor: 17.956

Review 3.  Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Authors:  Alisa D Blazek; Brian J Paleo; Noah Weisleder
Journal:  Physiology (Bethesda)       Date:  2015-11

Review 4.  Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

Authors:  Hugues Abriel; Jean-Sébastien Rougier; José Jalife
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

5.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

6.  Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.

Authors:  Liubov V Gushchina; Sayak Bhattacharya; Kevin E McElhanon; Jin Hyuk Choi; Heather Manring; Eric X Beck; Jenna Alloush; Noah Weisleder
Journal:  Mol Ther       Date:  2017-07-03       Impact factor: 11.454

Review 7.  Cardiac T-Tubule Microanatomy and Function.

Authors:  TingTing Hong; Robin M Shaw
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

8.  Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Authors:  Sree Rayavarapu; Jack H Van der Meulen; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju; Susan M Knoblach
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

9.  Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.

Authors:  Yongping Yue; Ibrahim M Binalsheikh; Stacey B Leach; Timothy L Domeier; Dongsheng Duan
Journal:  Expert Opin Orphan Drugs       Date:  2015-12-17       Impact factor: 0.694

10.  Mouse genome-wide association study identifies polymorphisms on chromosomes 4, 11, and 15 for age-related cardiac fibrosis.

Authors:  Qiaoli Li; Annerose Berndt; Beth A Sundberg; Kathleen A Silva; Victoria E Kennedy; Clinton L Cario; Matthew A Richardson; Thomas H Chase; Paul N Schofield; Jouni Uitto; John P Sundberg
Journal:  Mamm Genome       Date:  2016-04-28       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.